Neonax (AIO-PAK-0313): Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: A phase II study of the AIO Pancreatic Cancer Group

被引：0
|
作者：
Ettrich, Thomas Jens
Berger, Andreas W.
Muche, Rainer
Lutz, Manfred P.
Prasnikar, Nicole
Uhl, Waldemar
Tannapfel, Andrea
Heinemann, Volker
Seufferlein, Thomas
机构：
[1] Univ Ulm, Dept Internal Med 1, D-89069 Ulm, Germany
[2] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany
[3] Caritasklinikum, Saarbrucken, Germany
[4] Klinikum Ludwigsburg, Ludwigsburg, Germany
[5] Ruhr Univ Bochum, Dept Surg, Bochum, Germany
[6] Ruhr Univ Bochum, Dept Pathol, Bochum, Germany
[7] Univ Munich, Klinikum Grosshadern, Dept Med Oncol, D-80539 Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.tps497
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS497
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
    Sung Yong Han
    Dong Uk Kim
    Young Mi Seol
    Suk Kim
    Nam Kyung Lee
    Seung Baek Hong
    Hyung-Il Seo
    World Journal of Clinical Cases, 2020, (17) : 3718 - 3729
  • [32] nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: Real life
    Cidon, E. Una
    Alonso, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S109 - S109
  • [33] Efficacy and safety of Nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer
    Filipazzi, V.
    Dalu, D.
    Isabella, L.
    Tosca, N.
    Ferrario, S.
    Gambaro, A.
    Somma, L.
    Fasola, C.
    Pellegrini, I.
    Bombonati, G.
    Curcio, R.
    Damiani, E.
    Cattaneo, M. T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] Nab-paclitaxel plus gemcitabine as first line therapy in metastatic pancreatic cancer patients relapsed after gemcitabine adjuvant treatment
    Angelica Petrillo
    Annalisa Pappalardo
    Luca Pompella
    Giuseppe Tirino
    Filomena Calabrese
    Maria Maddalena Laterza
    Marianna Caterino
    Anna Ventriglia
    Michele Orditura
    Giovanni Conzo
    Carlo Molino
    Fortunato Ciardiello
    Maria Biglietto
    Ferdinando De Vita
    Medical Oncology, 2019, 36
  • [35] Nab-paclitaxel plus gemcitabine as first line therapy in metastatic pancreatic cancer patients relapsed after gemcitabine adjuvant treatment
    Petrillo, Angelica
    Pappalardo, Annalisa
    Pompella, Luca
    Tirino, Giuseppe
    Calabrese, Filomena
    Laterza, Maria Maddalena
    Caterino, Marianna
    Ventriglia, Anna
    Orditura, Michele
    Conzo, Giovanni
    Molino, Carlo
    Ciardiello, Fortunato
    Biglietto, Maria
    De Vita, Ferdinando
    MEDICAL ONCOLOGY, 2019, 36 (10)
  • [36] Phase II LAPACT Trial of Nab-Paclitaxel Plus Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
    Bekaii-Saab, Tanios
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (03) : 9 - 10
  • [37] Neo-adjuvant treatment in patients with pancreatic cancer with nab-paclitaxel and gemcitabine
    Pomillo, A.
    Santoro, M.
    Iuliano, E.
    Luci, M.
    Perricelli, A.
    Iuliano, F.
    Mazzulla, M. F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [38] A Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer Refractory to Gemcitabine Monotherapy
    Nishioka, Mariko
    Okano, Naohiro
    Wakabayashi, Masashi
    Ikeno, Takashi
    Hayashi, Masato
    Mizutani, Tomonori
    Nagashima, Fumio
    Furuse, Junji
    ANTICANCER RESEARCH, 2024, 44 (03) : 1233 - 1239
  • [39] A phase I study of intraperitoneal paclitaxel combined with gemcitabine plus nab-paclitaxel for pancreatic cancer with peritoneal metastasis
    Naminatsu Takahara
    Yousuke Nakai
    Hironori Ishigami
    Kei Saito
    Tatsuya Sato
    Ryunosuke Hakuta
    Kazunaga Ishigaki
    Tomotaka Saito
    Tsuyoshi Hamada
    Suguru Mizuno
    Hirofumi Kogure
    Hiroharu Yamashita
    Hiroyuki Isayama
    Yasuyuki Seto
    Kazuhiko Koike
    Investigational New Drugs, 2021, 39 : 175 - 181
  • [40] A phase I study of intraperitoneal paclitaxel combined with gemcitabine plus nab-paclitaxel for pancreatic cancer with peritoneal metastasis
    Takahara, Naminatsu
    Nakai, Yousuke
    Ishigami, Hironori
    Saito, Kei
    Sato, Tatsuya
    Hakuta, Ryunosuke
    Ishigaki, Kazunaga
    Saito, Tomotaka
    Hamada, Tsuyoshi
    Mizuno, Suguru
    Kogure, Hirofumi
    Yamashita, Hiroharu
    Isayama, Hiroyuki
    Seto, Yasuyuki
    Koike, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (01) : 175 - 181
12345